Advertisement

Age-Related Diseases of the Vitreous

  • Curtis E. Margo
Part of the Aging Medicine book series (AGME)

Abstract

The vitreous gel is a transparent, hypocellular tissue that effectively transmits light with negligible scatter or energy absorption. Although it is relatively resilient to age-related wear and tear, the vitreous is susceptible to injury from inflammatory cells and substances that breech the blood-retinal barrier. Over the course of a lifetime, the vitreous undergoes a variety of poorly understood, degenerative changes that lead to liquefaction—also referred to as syneresis. Vitreous syneresis is the most common predisposing factor for posterior vitreous detachment, which places a patient at risk for retinal detachment. While vision-threatening complications from deposits within the vitreous are uncommon (e.g., amyloid), the formation of vitreous membranes inflict considerable ocular morbidity. Vitreous membranes are a manifestation of a heterogeneous collection of disorders that share a final common pathway. Proliferative vitreoretinopathy (PVR) is the term applied to the uncontrolled growth of fibroglial membranes associated with rhegmatogenous retinal detachments. The most common reason for failed retinal reattachment surgery, PVR appears to exhibit an exaggerated reparative response to injury.

Keywords

amyloidosis asteroid hyalosis synchysis scintillans proliferative vitreoretinopathy (PVR) vitreous membranes syneresis retinal detachment posterior vitreous detachment (PVD) 

References

  1. 1.
    Fine BS, Yanoff M (1979) Ocular Histology, 2nd ed. Harper & Row, Hagerstown, p 131–145Google Scholar
  2. 2.
    Swann DA, Constable IJ, Harper E (1972) Vitreous structure. III. Composition of bovine vitreous collagen. Invest Ophthalmol Vis Sci 11:735–738Google Scholar
  3. 3.
    Swann DA, Caulfield JB, Broadhurst JB (1976) The altered fibrous form of vitreous collagen following solubilization with pepsin. Biochim Biophys Acta 427:365–369PubMedGoogle Scholar
  4. 4.
    Ayad S, Weiss JB (1984) A new look at vitreous humor collagen. Biochem J 218:835–840PubMedGoogle Scholar
  5. 5.
    Serry CM, Davison PF (1991) Collagens of the bovine vitreous. Invest Ophthalmol Vis Sci 32:1540–1550Google Scholar
  6. 6.
    Mayne R, Brewton RG, Mayne PM, Baker JR (1993) Isolation and characterization of the chains of type V/type XI collagen present in bovine vitreous. J Biol Chem 268:9381–9386PubMedGoogle Scholar
  7. 7.
    Shimokomaki M, Wright DW, Irwin MH, et al. (1990) The structure and macromolecular organization of type IX collagen in cartilage. Ann N Y Acad Sci 580:1–7PubMedCrossRefGoogle Scholar
  8. 8.
    Brewton RG, Wright DW, Mayne R (1991) Structural and functional comparison of type IX collagen-proteoglycan from chicken cartilage and vitreous humor. J Biol Chem 266:4752–4757PubMedGoogle Scholar
  9. 9.
    Bishop PN (2000) Structural macromolecules and supramolecular organization of the vitreous gel. Prog Retin Eye Res 19:323–344PubMedCrossRefGoogle Scholar
  10. 10.
    Atkins EDT, Sheehan JK (1972) Structure for hyaluronic acid. Nat New Biol 235:253–254PubMedCrossRefGoogle Scholar
  11. 11.
    Sheehan JK, Atkins ED, Niecluszynski IA (1975) X-ray diffraction studies on the connective tissue polysaccharides. Two-dimensional packing schemes for three fold hyaluronate chains. J Mol Biol 91:153–163PubMedCrossRefGoogle Scholar
  12. 12.
    Jose JG (1983) Vitreous humor. In: Anderson RE (ed) Biochemistry of the Eye, Ch 7. American Academy of Ophthalmology, San Francisco, p 145–162Google Scholar
  13. 13.
    Smith GN, Newsome DA (1978) The nature and origin of the glycosaminoglycans of the embryonic chick vitreous body. Dev Biol 62:65–77PubMedCrossRefGoogle Scholar
  14. 14.
    Klintworth GK (1994) Disorders of glycosaminoglycan and proteoglycans. In: Garner A, Klintworth GK (eds) Pathobiology of Ocular Disease, 2nd Edition, Ch 28. Dekker, New York, p 855–892Google Scholar
  15. 15.
    Cooper WC, Halbert SP, Manski WJ (1963) Immunocytochemical analysis of vitreous and subretinal fluid. Invest Ophthalmol 2:369–377PubMedGoogle Scholar
  16. 16.
    Scott JE (1992) The chemical morphology of the vitreous. Eye 6:553–555PubMedGoogle Scholar
  17. 17.
    Bos KJ, Holmes DR, Meadows RS, Kadler KE, McLeod D, Bishop PN (2001) Collagen fibril organization in mammalian vitreous by freeze etch/rotary shadowing electron microscopy. Micron 32:301–306PubMedCrossRefGoogle Scholar
  18. 18.
    Ren ZX, Brewton RG, Mayne R (1991) An analysis by rotary shadowing of the structure of the mammalian vitreous and zonular apparatus. J Struct Biol 106:57–63PubMedCrossRefGoogle Scholar
  19. 19.
    Schwarz W (1976) Electron microscopic study on the gel of the central part of the corpus vitreous in the ox. Cell Tissue Res 168:271–275PubMedCrossRefGoogle Scholar
  20. 20.
    Balazs EA, Toth LZ, Eckl EA, Mitchell AP (1964) Studies on the vitreous body. XII. Cytological and histochemical studies on the cortical tissue layers. Exp Eye Res 3:57–71PubMedCrossRefGoogle Scholar
  21. 21.
    Eisner G (1973) Biomicroscopy of the peripheral fundus. Springer-Verlag, BerlinGoogle Scholar
  22. 22.
    Worst JG (1977) Cisternal systems of the fully developed vitreous body in the young adult. Trans Ophthalmol Soc UK 97:550–554PubMedGoogle Scholar
  23. 23.
    Jongebloed WL, Worst JF (1987) The cisternal anatomy of the vitreous body. Doc Ophthalmol 67:183–196PubMedCrossRefGoogle Scholar
  24. 24.
    Sebag J (1989) The Vitreous. Structure, Function, Pathobiology. Springer-Verlag, New YorkGoogle Scholar
  25. 25.
    Sebag J, Balazs EA (1989) Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci 30:1867–1871PubMedGoogle Scholar
  26. 26.
    Sebag J (1991) Age-related differences in the human vitreoretinal interface. Arch Ophthalmol 109:966–971PubMedGoogle Scholar
  27. 27.
    Fine BS, Tousimis AJ (1961) The structure of the vitreous body and the supensory ligaments of the lens. Arch Ophthalmol 65:95–110PubMedGoogle Scholar
  28. 28.
    Gartner J (1962) Electron microscopic studies on the fine structure of the normal and pathologically changes vitreoretinal limiting membrane. Graefes Arch Clin Exp Ophthalmol 165:71–102Google Scholar
  29. 29.
    O'Malley P (1976) The pattern of vitreous syneresis. A study of 800 autopsy eyes. In: Irvine AR, O'Malley C (eds) Advances in Vitreous Surgery. Charles C. Thomas, Springfield, p 17–33Google Scholar
  30. 30.
    Sebag J (1994) Vitreous pathobiology. In: Tasman W, Jaeger EA (eds) Duane's Clinical Ophthalmology, vol 3. JB Lippincott Company, Philadelphia, p 4–5Google Scholar
  31. 31.
    Oksala A (1978) Ultrasonic findings in the vitreous body at various ages. Albrecht von Graefes Arch Klin Exp Ophthalmol 207:275–280PubMedCrossRefGoogle Scholar
  32. 32.
    Balazas EA, Denlinger JL Ageing changes in the vitreous. In: Ageing and Human Visual Function. Alan R. Liss, New York, pp 45–57Google Scholar
  33. 33.
    Los LI, van der Worp RJ, van Luyn MJ, Hooymans JM (2003) Age-related liquefaction of the human vitreous body: LM and TEM evaluation of the role of proteoglycans and collagen. Invest Ophthalmol Vis Sci 44:2828–2833PubMedCrossRefGoogle Scholar
  34. 34.
    Bishop PN, Holmes DF, Kadler KE, McLeod D, Bos KJ (2004) Age-related changes on the surface of vitreous collagen fibrils. Invest Ophthalmol Vis Sci 45:1041–1046PubMedCrossRefGoogle Scholar
  35. 35.
    Miller B, Miller H, Ryan SJ (1985) Experimental vitreous syneresis. Arch Ophthalmol 103:1385–1388PubMedGoogle Scholar
  36. 36.
    Lapcik L Jr, Omelka L, Kubena K, Galatik A, Kello V (1990) Photodegradation of hyaluronic acid and the vitreous body. Gen Physiol Biophys 9:419–429PubMedGoogle Scholar
  37. 37.
    Ueno N, Sebag J, Hirokawa H, Chakrabarti B (1987) Effects of visible-light irradiation on vitreous structure in the presence of a photosensitizer. Exp Eye Res 44:863–870PubMedCrossRefGoogle Scholar
  38. 38.
    Margo CE, Harman LE (2005) Posterior vitreous detachment. How to approach sudden-onset floaters and flashing lights. Postgrad Med 117:37–42Google Scholar
  39. 39.
    Heller MD, Straatsma BR, Foos RY (1972) Detachment of the posterior vitreous in phakic and aphakic eyes. Med Probl Ophthalmol 10:23–36Google Scholar
  40. 40.
    Larsson L, Osterlin A(1985) Posterior vitreous detachment. A combined clinical and phyio-chemical study. Graefes Arch Clin Exp Ophthalmol 223:92–95PubMedCrossRefGoogle Scholar
  41. 41.
    Kishi S, Shimizu K (1990) Posterior precortical vitreous pocket. Arch Ophthalmol 108:979–982PubMedGoogle Scholar
  42. 42.
    Tamura T, Kishi S (1993) Scanning electron microscopic findings of the premacular vitreous in eyes without posterior vitreous detachment. Nippon Ganka Gakkai Zasshi 97:1197–1202PubMedGoogle Scholar
  43. 43.
    Pischel DK (1952) Detachment of the vitreous as seen with slit lamp examination. Trans Am Ophthalmol Soc 50:329–346PubMedGoogle Scholar
  44. 44.
    Buzney SM, Weiter JJ, Furukawa H, et al. (1985) Examination of the vitreous: a comparation of biomicroscopy using the Goldmann and El Bayadi-Kajiura lenses. Ophthalmology 92:1745–1748PubMedGoogle Scholar
  45. 45.
    Foos RY (1972) Posterior vitreous detachment. Trans Am Acad Ophthalmol Otolaryngol 76:480–497PubMedGoogle Scholar
  46. 46.
    Streeten BW, Wilson DD (1994) Disorders of the vitreous. In: Garner A, Klintworth GK (eds) Pathobiology of Ocular Disease: A Dynamic Approach, 2nd Ed., Ch 22. Marcel Dekker, Inc., New York, p 701–742Google Scholar
  47. 47.
    Jaffe NS (1968) Complications of acute posterior vitreous detachment. Arch Ophthalmol 79:568–571PubMedGoogle Scholar
  48. 48.
    Linder B (1966) Acute posterior vitreous detachment and its retinal complications: a clinical biomicroscopic study. Acta Ophthalmol 87 (suppl):1–108Google Scholar
  49. 49.
    Novak MA, Welch RB (1984) Complications of acute symptomatic posterior vitreous detachment. Am j Ophthalmol 97:308–314PubMedGoogle Scholar
  50. 50.
    Tasman W (1983) Rhegmatogenous retinal detachment caused by focal paravacular vitreoreti-nal traction. Trans Pa Acad Ophthalmol Otolyngol 36:146–148Google Scholar
  51. 51.
    Theodossiadis GP, Koutsandrea CN (1985) Avulsed retinal vessels with and without retinal breaks. Treatment and extended follow up. Trans Ophthalmol Soc UK 104:887–892PubMedGoogle Scholar
  52. 52.
    Kanski JJ (1975) Complications of acute posterior vitreous detachment. Am J Ophthalmol 80:44–46PubMedGoogle Scholar
  53. 53.
    Tani P, Robertson DM, Langworthy A (1980) Rhegmatogenous retinal detachment without macular involvement treated with scleral buckle. Am J Ophthalmol 90:503–508PubMedGoogle Scholar
  54. 54.
    Brod RD, Lightman DA, Packer AJ, Saras HP (1991) Correlation between vitreous pigment granules and retinal breaks in eyes with acute posterior vitreous detachment. Ophthalmology 98:1366–1369PubMedGoogle Scholar
  55. 55.
    Tasman WS (1968) Posterior vitreous detachment and peripheral retinal breaks. Trans Am Acad Ophthalmol Otolaryngol 72:217–224PubMedGoogle Scholar
  56. 56.
    Boldrey EE (1983) Risk of retinal tears in patients with vitreous floaters. Am J Ophthalmol 96:783–787PubMedGoogle Scholar
  57. 57.
    Sarrafizadeh R, Hassan TS, Ruby AJ, et al. (2001) Incidence of retinal detachment and visual outcome in eyes presenting with posterior vitreous separation and dense fundus-obscuring vitreous hemorrhage. Ophthalmology 108:2273–2278PubMedCrossRefGoogle Scholar
  58. 58.
    Green WR (1989) Vitreoretinal juncture. In: Ryan (ed) Retina, vol 3, ch 117. Mosby, Philadelphia, 13–69Google Scholar
  59. 59.
    Hersh PS, Green WR, Thomas JV (1981) Tractional venous loops in diabetic retinopathy. Am J Ophthalmol 92:661–671PubMedGoogle Scholar
  60. 60.
    Vine AK (1984) Avulsed retinal veins without retinal breaks. Am J Ophthalmol 98:723–727PubMedGoogle Scholar
  61. 61.
    Dayan MR, Jayamanne DG, Andrews RM, Griffiths PG (1996) Flashes and floaters as predictors of vitreoretinal pathology: is follow-up necessary for posterior vitreous detachment? Eye 10:456–458PubMedGoogle Scholar
  62. 62.
    Byer NE (1994) Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment. Ophthalmology 101:1513–1514Google Scholar
  63. 63.
    Retinal Panel (1998) Preferred Practice Patterns. Management of Posterior Vitreous detachment, retinal breaks, and lattice degeneration. American Academy of Ophthalmology, San FranciscoGoogle Scholar
  64. 64.
    Robertson DM, Norton EWD (1973) Long-term follow-up of treated retinal breaks. Am J Ophthalmol 75:395–404PubMedGoogle Scholar
  65. 65.
    Pollack A, Oliver M (1981) Argon laser photocoagulation of symptomatic flap tears and retinal breaks of fellow eyes. Br J Ophthalmol 1981;65:469–472CrossRefGoogle Scholar
  66. 66.
    Smiddy WE, Flynn HW Jr. Nicholson DH, et al. Results and complications in treated retinal breaks. Am J Ophthalmol 112:623–631Google Scholar
  67. 67.
    Sigelman J (1980) Vitreous base classification of retinal tears: clinical application. Surv Ophthalmol 25:59–70PubMedCrossRefGoogle Scholar
  68. 68.
    Byer NE (1998) What happens to untreated asymptomatic retinal breaks, and are they affected by posterior vitreous detachments? Ophthalmology 105:1045–1050PubMedCrossRefGoogle Scholar
  69. 69.
    Davis MD (1974) Natural history of retinal breaks without detachment. Arch Ophthalmol 92:183–194PubMedGoogle Scholar
  70. 70.
    Colyear BH Jr, Pischel D (1960) Preventive treatment of retinal detachment by means of light coagulation. Trans Pac Coast Oto Ophthalmol Soc Annu Meet 41:193–217Google Scholar
  71. 71.
    Wilkerson CP (2000) Evidence-based analysis of prophylactic treatment of asymptomatic retinal breaks and lattice degeneration, Discussion 15–8. Ophthalmology 107:12–5CrossRefGoogle Scholar
  72. 72.
    Haimann MH, Burton TC, Brown CK (1982) Epidemiology of retinal detachment. Arch Ophthalmol 100:289–292PubMedGoogle Scholar
  73. 73.
    Wilkes SR, Beard CM, Kurland LT, Robertson DM, O'Fallon WM (1982) The incidence of retinal detachment in Rochester, Minnesota, 1970–1978. Am J Ophthalmol 94:670–673PubMedGoogle Scholar
  74. 74.
    Benson WE, Morse PH (1978) The prognosis of retinal detachment due to lattice degeneration. Ann Ophthalmol 10;1197–1200PubMedGoogle Scholar
  75. 75.
    Byer NE (1989) Long-term natural history of lattice degeneration of the retina. Ophthalmology 96:1396–1401PubMedGoogle Scholar
  76. 76.
    Suhr OB, Svendsen IH, Andersson R, et al. (2003) Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med 254:225–235PubMedCrossRefGoogle Scholar
  77. 77.
    Buxbaum JN (2005) The systemic amyloidosis. Curr Opin Rheumatoid 16:67–75CrossRefGoogle Scholar
  78. 78.
    Margo CE (1986) Corneal amyloid: selecting the right histochemical stain. Cornea 5:125–126CrossRefGoogle Scholar
  79. 79.
    Ando Y, Nakamura M, Araki S (2005) Transthyretin-related familial amyloidotic polyneurop-athy. Arch Neurol 62:1057–1062PubMedCrossRefGoogle Scholar
  80. 80.
    Sasaki H, Yoshioka N, Takagi Y, Sakaki Y (1985) Structure of the chromosomal gene for human serum prealbumin. Gene 37:191–197PubMedCrossRefGoogle Scholar
  81. 81.
    Schwartz MF, Green WR, Michels RG, Kincaid MC, Fogle J (1982) An unusual case of ocular involvement in primary systemic nonfamilial amyloidosis. Ophthalmology 89:394–401PubMedGoogle Scholar
  82. 82.
    Biswas J, Badrinath SS, Rao NA (1992) Primary nonfamilial amyloidosis of the vitreous. A light microscopic and ultrastructural study. Retina 12:251–253PubMedCrossRefGoogle Scholar
  83. 83.
    Ferry AP, Lieberman TW (1976) Bilateral amyloidosis of the vitreous body. Arch Ophthalmol 94:982–991PubMedGoogle Scholar
  84. 84.
    Woeber KA, Ingbar SH (1968) The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum as assessed by immunoadsorption. J Clin Invest 47:1710–1721PubMedCrossRefGoogle Scholar
  85. 85.
    Ciulla TA, Tolentino F, Morrow JF, Dryja TP (1995) Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with Val30Met transthyretin mutation. Surv Ophthalmol 40:197–201PubMedCrossRefGoogle Scholar
  86. 86.
    Sandgren O (1995) Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 40:173–196PubMedCrossRefGoogle Scholar
  87. 87.
    Sandgrene O, Drugge U, Holmgren G, Sousa A (1991) Vitreous involvement in familial amyoidotic neuropathy: a genealogical and genetic study. Clin Genet 40:452–60CrossRefGoogle Scholar
  88. 88.
    Wong VG, McFarlin DE (1967) Primary familial amyloidosis. Arch Ophthalmol 78:208–213PubMedGoogle Scholar
  89. 89.
    Streeten BAW, Wilson DJ (1994) Disorders of the vitreous. In, Garner A, Klintworth GK (eds), Pathobiology of Ocular Disease. A Dynamic Approach. Second Edition, New York, Marcel Dekker, Inc. Ch 22, 701–742Google Scholar
  90. 90.
    Irvine AR, Char DH (1976) Recurrent amyloid involvement in the vitreous body after vitrectomy. Am J Ophthalmol 82:705–708PubMedGoogle Scholar
  91. 91.
    Doft BH, Machemer R, Skinner M, et al. (1987) Pars plana vitrectomy for vitreous amyloidosis. Ophthalmology 94:607–611PubMedGoogle Scholar
  92. 92.
    Bene C, Kranias G (1990) Ocular amyloidosis: clinical points learned from one case. Ann Ophthalmol 22:101–102PubMedGoogle Scholar
  93. 93.
    Comenzo RL (2007) Current and emergin views and treatments of systemic immunoglobulin light-chain (AL) amyloidosis. Contrib Nephrol 153:195–210PubMedCrossRefGoogle Scholar
  94. 94.
    Benson AH (1894) A case of monocular asteroid hyalites. Trans Ophthalmol Soc UK 14:101–104Google Scholar
  95. 95.
    Luxenberg M, Sime D (1969) Relationship of asteroid hyalosis to diabetes mellitus ad plasma lipid levels. Am J Ophthalmol 67:406–413PubMedGoogle Scholar
  96. 96.
    Bergren RL, Brown GC, Duker JS (1991) Prevalence and association of asteroid hyaloisis with systemic diseases. Am J Ophthalmol 111:289–293PubMedGoogle Scholar
  97. 97.
    Hatfield RE, Gastineau CF, Rucker CW (1962) Asteroid bodies in the vitreous: relationship to diabetes and hypercholesterolemia. Mayo Clin Proc 37:513–514Google Scholar
  98. 98.
    Rodman HJ, Johnson FB, Zimmerman LE (1961) New histopathological and histochemical observations concerning asteroid hyalites. Arch Ophthalmol 66:552–563PubMedGoogle Scholar
  99. 99.
    March W, Shock D, O'Grady R (1974) Composition of asteroid bodies. Invest Ophthalmol Vis Sci 13:701–705Google Scholar
  100. 100.
    Streeten BW (1982) Vitreous asteroid bodies: ultrastructural characteristics and composition. Arch Ophthalmol 100:969–675PubMedGoogle Scholar
  101. 101.
    Swann DA, Constable IJ, Harper E (1972) Vitreous structure: Composition of bovine vitreous collagen. Invest Ophthalmol Vis Sci 11:735–738Google Scholar
  102. 102.
    Miller H, Miller B, Rabinowitz H, Zonis S, Nir I (1983) Asteroid bodies: an ultrastructural study. Invest Ophthalmol Vis Sci 24:133–136PubMedGoogle Scholar
  103. 103.
    Topilow HW, Kenyon KR, Takahashi M, et al. (1982) Asteroid hyalosis: Biomicroscopy, ultrastructure and composition. Arch Ophthalmol 100:964–968PubMedGoogle Scholar
  104. 104.
    Wand M, Smith TR, Cogan DG (1975) Cholesterolosis bulbi: the ocular abnormality known as synchysis scintillans. Am J Ophthalmol 80:177–183PubMedGoogle Scholar
  105. 105.
    Jacobson B, Basu PK, Hasany SM (1984) Vascular endothelial cell growth inhibitor of normal and pathologic human vitreous. Arch Ophthalmol 102:1543–1545PubMedGoogle Scholar
  106. 106.
    Jacobsen B, Dorfman T, Basu PK, Hasany SM (1985) Inhibition of vascular endothelial cell growth and trypsin activity by vitreous. Exp Eye Res 41:581–595CrossRefGoogle Scholar
  107. 107.
    Lutty GA, Mello RJ, Chandler C, et al. (1985) Regulations of cell growth by vitreous humor. J Cell Sci 76:53–65PubMedGoogle Scholar
  108. 108.
    Lutty GA, Thompson DC, Gallop J Y, et al. (1983) Vitreous: an inhibitor of retinal extract-induced neovasclarization. Invest Ophthalmol Vis Sci 24:52–56PubMedGoogle Scholar
  109. 109.
    Grant M, Russell B, Fitzgerald C, Merimee TJ (1986) Insulin-like growth factors in vitreous: Studies in control and diabetic subjects with neovascularization. Diabetes 35:416–420PubMedCrossRefGoogle Scholar
  110. 110.
    Sivalingam A, Kennery J, Brown GC, et al. (1990) Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 108:869–872PubMedGoogle Scholar
  111. 111.
    Uchichori Y, Puro DG (1991) Mitogenic and chemotactic effects of platelet-derived growth factor on human retinal glial cells. Invest Ophthalmol Vis Sci 32:2689–2695Google Scholar
  112. 112.
    Yeo JH, Sadeghi J, Campochiaro PA, Green WR, Glaser BM (1998) Intravitreous fibronectin and platelet-derived growth factor: New model for traction retinal detachment. Arch Ophthalmol 104:417–421Google Scholar
  113. 113.
    Kampik A, Kenyon K, Michels R, et al. (1981) Epiretinal membranes. Arch Ophthalmol 99:1445–1454PubMedGoogle Scholar
  114. 114.
    Zacks DN, Johnson MW (2004) Transretinal pigment migration: an optical coherence tomo-graphic study. Arch Ophthalmol 122:406–408PubMedCrossRefGoogle Scholar
  115. 115.
    Foos RY (1977) Vitreoretinal juncture; epiretinal membranes and vitreous. Invest Ophthalmol Vis Sci 16:416–422PubMedGoogle Scholar
  116. 116.
    Clarkson JG, Green WR, Massof D (1977) Histopathologic review of 168 cases of preretinal membranes. Am J Ophthalmol 84:1–17PubMedGoogle Scholar
  117. 117.
    Gass JD (1988) Idiopathic senile macular hole: Its early stages of pathogenesis. Arch Ophthalmol 106:629–639PubMedGoogle Scholar
  118. 118.
    Bellhorn MB, Friedman AH, Wise GN, Henkind P (1975) Ultrastructure and clinicopatho-logic correlation of idiopathic prereitnal macular fibrosis. Am J Ophthalmol 79:366–373PubMedGoogle Scholar
  119. 119.
    Smiddy WE, Magure AM, Green WR, et al. (1989) Idiopathic epiretinal membranes, ultrastructural characteristics and clinicopathologic correlation. Ophthalmology 96:811–821PubMedGoogle Scholar
  120. 120.
    Girard P, Mimoun G, Karpouzas I. Montefiore G (1994) Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 14:417–424PubMedCrossRefGoogle Scholar
  121. 121.
    Asaria RH, Charteris DG (2006) Proliferative vitreoretinopathy: developments in pathogen-esis and treatment. Compr Ophthalmol Update 7:179–185PubMedGoogle Scholar
  122. 122.
    Machemer R, Laqua H (1975) Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:1–23PubMedGoogle Scholar
  123. 123.
    Machemer R. Aaberg TM (1978) Pigmenet epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol 85:181–191PubMedGoogle Scholar
  124. 124.
    Aquirrebena A, Saornil MA, Giraldo A, Pastor JC (1986) Incidnce de la vitreorretinoptia proliferarante (VRP) en el desprendimiento de retina regmatogeno. Arch Soc Esp Oftalmol 51:229–234Google Scholar
  125. 125.
    Bonnet M (1984) Clinical factors predisposing to massive proliferative vitreoretinopathy in rhegmatogenous retinal detachment. Ophthalmologia (Basel) 188:148–152Google Scholar
  126. 126.
    Cowley M, Conway BP, Campochiaro RA, et al. (1989) Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol 107:1147–1151PubMedGoogle Scholar
  127. 127.
    Bonnet M, Guenoun S (1995) Surgical risk factors for severe postoperative proliferative vit-reoretinopathy (PVR) in retinal detachment with grade B PVR. Graefes Arch Clin Exp Ophthalmol 233:789–791PubMedCrossRefGoogle Scholar
  128. 128.
    Charteris DG, Hiscott P, Grieson I, Lightman S (1992) Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes. Ophthalmology 99:1364–1367PubMedGoogle Scholar
  129. 129.
    Scheiffarth OF, Kampik A, Gunther-Koszka H, Vo n der Mark K (1989) Collagens, fibronec-tin and laminin in proliferative vitreoretinopathy. In: Heimann K, Wiedemann P (eds) Proliferative Vitreoretinopathy. Kaden, Heidelberg, p 134–138Google Scholar
  130. 130.
    Pastor JC (1998) Proliferative vitreoretinopathy: An overview. Surv Ophthalmol 43:3–18PubMedCrossRefGoogle Scholar
  131. 131.
    Wiedemann P (1992) Growth factors in retinal disease: proliferative vitreoretinopathy, pro-liferative diabetic retinopathy and retinal degeneration. Surv Ophthalmol 36:373–384PubMedCrossRefGoogle Scholar
  132. 132.
    Retina Society Terminology Committee. (1983) The classification of retinal detachment with proliferative viteoretinopathy. Ophthalmology 90:121–125Google Scholar
  133. 133.
    Lean JS, Stern WH, Irvine A, Azen SP (1989) The Silicone Study Group. Classification of proliferative vitreoretinopathy used in the Silicone Study. Ophthalmology 96:756–771Google Scholar
  134. 134.
    Campochiaro PA, Kaden IH, Vidaurri-Lead J, Glaser BM (1985) Cryotherapy enhances intrav-itreal dispersion of viable retinal pigment epithelial cells. Arch Ophthalmol 103:434–4360PubMedGoogle Scholar
  135. 135.
    Glaser B (1989) Surgery for proliferative viteoretinopathy. In: Glaser B, Michels RG (eds) Retina, vol 3, Ch 138. CV Mosby Company, St Louis, p 385–400Google Scholar
  136. 136.
    Machemer R (1980) Surgical approaches to subretinal strands. Am J Ophthalmol 90:81–85PubMedGoogle Scholar
  137. 137.
    Gentile RC, Abrams GW (1998) The Silicone Study. In: Kertes PJ, Conway MD (eds) Clinical Trials in Ophthalmology, Ch 10. Lippinocott Williams & Wilkins, Philadelphia, 163–184Google Scholar
  138. 138.
    The Silicone Study Group. (1992) Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy. Results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol 110:770–779Google Scholar
  139. 139.
    The Silicone Study. (1992) Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Results of a randomized clinical trial. Silicone Study Report 2. Arch Ophthalmol 110:780–792Google Scholar
  140. 140.
    Abrams GW, Azen SP, McCuen BW, et al. (1997) Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow up. Silicone Study Report 11. Arch Ophthalmol 115:335–344PubMedGoogle Scholar
  141. 141.
    Tseng W, Cortez RT, Ramirez G, et al. (2004) Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoreti-nal surgery. Am J Ophthalmol 137:1105–1115PubMedCrossRefGoogle Scholar
  142. 142.
    Young SE, Cruciger M, Lukeman J (1979) Metastatic carcinoma to the retina: A care report. Ophthalmology 86:1350–1354PubMedGoogle Scholar
  143. 143.
    Freeman LN, Schachat AP, Knox DL, et al. (1987) Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 94:1631–1639PubMedGoogle Scholar
  144. 144.
    Schabet M (1999) Epidemiology of primary CNS lymphoma. J Neurooncol 43:199–201PubMedCrossRefGoogle Scholar
  145. 145.
    Akpek EK, Ahmed I, Hochbert FH, et al. (1999) Intraocular-central nervous system lym-phoma: clinical features, diagnosis, and outcomes. Ophthalmology 106:1805–1810PubMedCrossRefGoogle Scholar
  146. 146.
    Whipcup SM, de Smet MD, Rubin BI, et al. (1993) Intraocular lymphoma. Clinical and his-topathologic diagnosis. Ophthalmology 100;1399–1406Google Scholar
  147. 147.
    Chan D-D, Wallace DJ (2004) Intraocular lymphoma: update on diagnosis and management. Cancer Control 11:285–1295PubMedGoogle Scholar
  148. 148.
    Hormigo A, DeAngelis LM (2003) Primary ocular lymphoma: clinical features, diagnosis and treatment. Clin Lymphoma. 4:22–9PubMedCrossRefGoogle Scholar
  149. 149.
    Davis JL, Solomon D. Nussenblatt RB, et al. (1992) Immunocytochemical staining of vitreous cells. Indications, techniques, and results. Ophthalmology 99:250–256PubMedGoogle Scholar
  150. 150.
    Pavan PR, Oteiza E, Margo CE (1995) Ocular lymphoma diagnosed by internal subretinal pigment epithelial biopsy. Arch Ophthalmol 113:1233–1234PubMedGoogle Scholar
  151. 151.
    Kirmant MH, Thomas EL, Rao NA, et al. (1987) Intraocular reticulum cell sarcoma: diagnosis by choroidal biopsy. Br J Ophthalmol 71:748–752CrossRefGoogle Scholar
  152. 152.
    Bagg A, Kallakury BL (1999) Molecular pathology of leukemia and lymphoma. Am J Clin Pathol 112(Suppl 1):S76–S92PubMedGoogle Scholar
  153. 153.
    Davis JL, Viciana AL, Ruiz P. (1997) Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol 124:362–372PubMedGoogle Scholar
  154. 154.
    Coupland SE, Bechrakis NE, Anastassiou G, et al. (2003) Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with masquerade syndrome. Grafes Arch Clin Exp Ophthalmol 241:362–372CrossRefGoogle Scholar
  155. 155.
    Char DH, Lhung BM, Deschenes J, et al. (1988) Intraocular lymphoma: immunological and cytological analysis. Br J Ophthalmol 72:905–911PubMedCrossRefGoogle Scholar
  156. 156.
    Rothova A, Ooijman F, Kerkhoff F, et al. (2002) Uveitis masquerade syndrome. Ophthalmology 108:386–399CrossRefGoogle Scholar
  157. 157.
    Shen DF, Zhuang Z, LeHoang P, et al. (1998) Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology 105:1664–1669PubMedCrossRefGoogle Scholar
  158. 158.
    Gorochov G, Parizot C, Bodaghi B, et al. (2003) Characterization of vitreous B-cell infiltrates in patients with primary ocular lymphoma, using CDR3 size polymorphism analysis of antibody transcripts. Invest Ophthalmol Vis Sci 44:5235–5241PubMedCrossRefGoogle Scholar
  159. 159.
    Chan CC (2003) Molecular pathology of primary intraocular lymphomas. Trans Am Ophthalmol Soc 101:275–292PubMedGoogle Scholar
  160. 160.
    Chan CC, Whitcup SM, Solomon D, et al. (1995) Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol 120:671–673PubMedGoogle Scholar
  161. 161.
    Whitcup SM, Stark-Vancs V, Wittes RE, et al. (1997) Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 115:1157–1160PubMedGoogle Scholar
  162. 162.
    Cassoux N, Merle-Beral H, LeHoang P, et al. (2001) Interleukin-10 and intraocular-central nervous system lymphoma. Ophthalmology 108:426–427PubMedCrossRefGoogle Scholar
  163. 163.
    Akpek EK, Maca SM, Christen WG, et al. (1999) Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology 106:2291–2295PubMedCrossRefGoogle Scholar
  164. 164.
    Buggage RR, Velez G, Myers-Powell B, et al. (1999) Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH gene rearrangement. Arch Ophthalmol 117:1239–1242PubMedGoogle Scholar
  165. 165.
    Sandor V, Stark-Vancs V, Pearson D, et al. (1998) Phase II trial of chemotherapy alone for primary CNS intraocular lymphoma. J Clinic Oncol 16:3000–6. Comments: Henson JW, Yang J, Batchelor T (1999) Intraocular methotrexate level after high-dose intravenous infusion. J Clin Oncol 17:1329Google Scholar
  166. 166.
    Baumann MA, Ritch PS, Hande KR, et al. (1986) Treatment of intraocular lymphoma with high-dose Ara-C. Cancer 57:1273–1275PubMedCrossRefGoogle Scholar
  167. 167.
    Strauchen JA, Dalton J, Friedman AH (1989) Chemotherapy in the management of intraocular lymphoma. Cancer 63:1918–1921PubMedCrossRefGoogle Scholar
  168. 168.
    Valluri S, Moorthy RS, Khan A, et al. (1995) Combination treatment of intraocular lymphoma. Retina 15:125–129PubMedCrossRefGoogle Scholar
  169. 169.
    Ferreri AJ, Blay JY, Reni M, et al. (2002) Relevance of intraocular involvement in the management of primary central nervous system lymphoma. Ann Oncol 13:531–538PubMedCrossRefGoogle Scholar
  170. 170.
    Ishburne BC, Wilson DJ, Rosenbaum JT, et al. (1997) Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 115:1152–1156Google Scholar
  171. 171.
    Smith JR, Rosenbaum JT, Wilson DJ, et al. (2002) Role of intravitreal methotrexate in the management of primary central nervous system lymphomas with ocular involvement. Ophthalmology 109:1709–1716PubMedCrossRefGoogle Scholar
  172. 172.
    De Smet MD, Vancs VS, Kohler D, et al. (1999) Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol 83:448–451PubMedCrossRefGoogle Scholar
  173. 173.
    Soussain C, Suzan F, Hoang-Xuan K, et al. (2001) Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 19:742–749PubMedGoogle Scholar
  174. 174.
    DeAngelis LM (2001) Brain tumors N Engl J Med 344:114–123Google Scholar
  175. 175.
    Nasir S, DeAngelis LM (2000) Update on the management of primary CNS lymphoma. Oncology (Huningt) 14:228–234Google Scholar
  176. 176.
    Lindgren G, Sjodell L, Lindblom, B (1995) A prospective study of dense spontaneous vitreous hemorrhage. Am J Ophthalmol 119:458–465PubMedGoogle Scholar
  177. 177.
    Spraul CW, Grossniklaus HE (1997) Vitreous hemorrhage. Surv Ophthalmol 42:3–39PubMedCrossRefGoogle Scholar
  178. 178.
    Dana WR, Werner MS, Viana MA, Shapiro MJ (1993) Spontaneous and traumatic vitreous hemorrhage. Ophthalmology 100:1377–1383PubMedGoogle Scholar
  179. 179.
    Feman SS, Barlett RE, Roth AM, Foos RY (1972) Intraocular hemorrhage and blindness associated with systemic anticoagulation. JAMA 220:1354–1355PubMedCrossRefGoogle Scholar
  180. 180.
    El Baba FE, Jarrett WH, Harbin TS, et al. (1986) Massive hemorrhage complicating age-related macular degeneration. Ophthalmology 93:1581–1592PubMedGoogle Scholar
  181. 181.
    Swann DA, Chesney C, Constable IJ, et al. (1974) The role of vitreous collagen in platelet aggregation in vitro and in vivo. J Lab Clin Med 84:264–274PubMedGoogle Scholar
  182. 182.
    Wolter JR (1960) The macrophages of the human vitreous body. Am J Ophthalmol 49:1185–1193PubMedGoogle Scholar
  183. 183.
    Greer DR, Benson WE, Spalter HF (1968) A study of simulated vitreous hemorrhages using labeled blood. Arch Ophthalmol 79:755–758PubMedGoogle Scholar
  184. 184.
    Boyer HK, Suran A, Hogan MJ, et al. (1958) Studies on simulated vitreous hemorrhages. I. Rate of disappearance of radiochromium tagged red cells. Arch Ophthalmol 59:232–234Google Scholar
  185. 185.
    Grossniklaus HE, Frank KE, Farhi DC, et al. (1988) Hemoglobin spherulosis in the vitreous cavity. Arch Ophthalmol 106:961–962PubMedGoogle Scholar
  186. 186.
    Van Bockzmeer FM, Martin CE, Constable IJ (1983) Iron-binding proteins in vitreous humour. Biochim Biophys Acta 758:17–23Google Scholar
  187. 187.
    Declercq SS, Meredith CA, Rosenthal AR (1977) Experimental siderosis in the rabbit. Arch Ophthalmol 95:1051–1058PubMedGoogle Scholar
  188. 188.
    Burger PC, Klintworth GK (1974) Experimental retinal degeneration in the rabbit produced by intraocular iron. Lab Invest 30:9–19PubMedGoogle Scholar
  189. 189.
    Ehrenberg M, Thresher RJ, Machemer R (1984) Vitreous hemorrhage nontoxic to retina as a stimulator of glial and fibrous proliferation. Am J Ophthalmol 97:611–626PubMedGoogle Scholar
  190. 190.
    Lean JS, Gregor Z (1980) The acute vitreous hemorrhage. Br J Ophthalmol 64:469–471PubMedCrossRefGoogle Scholar
  191. 191.
    Thompson JT, de Bustros S, Michels RG, Rice TA (1987) Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage. Arch Ophthalmol 105:191–195PubMedGoogle Scholar
  192. 192.
    Diabetic Retinopathy Vitrectomy Study Research Group (1988) Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial-report number 3. Ophthalmology 95:1307–1320Google Scholar
  193. 193.
    Diabetic Retinopathy Vitrectomy Study Research Group. (1985) Early vitrctomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial-report number 2. Arch Ophthalmol 103:1644–1652Google Scholar
  194. 194.
    Diabetic Retinopathy Vitrectomy Study Research Group. (1990) Early vitrctomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial-report number 5. Arch Ophthalmol 108:958–964Google Scholar
  195. 195.
    Tanaka M, Qui H (2000) Pharmacological vitrectomy. Semin Ophthalmol 15:51–61PubMedCrossRefGoogle Scholar
  196. 196.
    Kuppermann BD, Thomas EL, de Smet MD, et al. (2005) Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 140:573–584PubMedCrossRefGoogle Scholar
  197. 197.
    Kupperman BD, Thomas EL, de Smet MD, et al. (2005) Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 140:585–597CrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Curtis E. Margo
    • 1
  1. 1.Ophthalmic Pathology Laboratory, Ophthalmology and PathologyUniversity of South Florida College of MedicineTampaUSA

Personalised recommendations